2Xideas AG Cuts Stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

2Xideas AG reduced its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 38.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 153,897 shares of the company’s stock after selling 96,740 shares during the quarter. 2Xideas AG owned approximately 0.06% of Ryan Specialty worth $9,874,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the company. Federated Hermes Inc. raised its position in shares of Ryan Specialty by 11.4% in the fourth quarter. Federated Hermes Inc. now owns 656,963 shares of the company’s stock worth $42,150,000 after acquiring an additional 67,310 shares during the period. Waterloo Capital L.P. boosted its holdings in shares of Ryan Specialty by 46.9% during the 4th quarter. Waterloo Capital L.P. now owns 9,589 shares of the company’s stock worth $615,000 after purchasing an additional 3,061 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in Ryan Specialty in the 4th quarter valued at $545,000. Mizuho Bank Ltd. purchased a new position in Ryan Specialty during the fourth quarter worth about $49,000. Finally, Nicolet Advisory Services LLC raised its position in shares of Ryan Specialty by 9.3% during the 4th quarter. Nicolet Advisory Services LLC now owns 11,301 shares of the company’s stock valued at $706,000 after buying an additional 963 shares during the period. 84.82% of the stock is currently owned by institutional investors.

Ryan Specialty Price Performance

NYSE RYAN opened at $70.55 on Friday. Ryan Specialty Holdings, Inc. has a 12 month low of $48.48 and a 12 month high of $77.16. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The company’s 50 day simple moving average is $69.60 and its 200 day simple moving average is $68.64. The firm has a market capitalization of $18.48 billion, a PE ratio of 102.25, a P/E/G ratio of 1.19 and a beta of 0.66.

Ryan Specialty (NYSE:RYAN) last released its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The firm had revenue of $663.53 million during the quarter, compared to analysts’ expectations of $658.80 million. As a group, equities research analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were issued a $0.12 dividend. The ex-dividend date was Tuesday, March 4th. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.11. This represents a $0.48 dividend on an annualized basis and a yield of 0.68%. Ryan Specialty’s dividend payout ratio is currently 69.57%.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on RYAN. UBS Group increased their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a “buy” rating in a research report on Wednesday, February 26th. Royal Bank of Canada decreased their price target on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a research note on Friday, February 21st. Keefe, Bruyette & Woods cut their target price on Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating on the stock in a research report on Friday, February 21st. Finally, Wells Fargo & Company upped their price objective on shares of Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a research note on Friday, February 21st. One research analyst has rated the stock with a sell rating, six have issued a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $75.27.

Insider Activity

In related news, Director Nicholas Dominic Cortezi sold 35,000 shares of the company’s stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $65.99, for a total value of $2,309,650.00. Following the sale, the director now owns 35,609 shares of the company’s stock, valued at $2,349,837.91. The trade was a 49.57 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. In the last quarter, insiders have sold 241,360 shares of company stock valued at $16,006,428. Insiders own 11.10% of the company’s stock.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.